Differentiation-promoting effect of 1-O (2 methoxy) hexadecyl glycerol in human colon cancer cells

Journal of Cellular Physiology

Volumn 178, Issue 2, 1999, Pages 173-178

  Wang, Hongmei ^a   Rajagopal, Sriram ^a   Reynolds, Sharon ^a   Cederberg, Hokan ^b   Chakrabarty, Subhas ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Scandinavian Pharmaceutical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (2 METHOXYHEXADECYL)GLYCEROL; CARCINOEMBRYONIC ANTIGEN; FIBRONECTIN; GLYCEROL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; COLON CANCER; DOWN REGULATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; FIBRONECTINS; GLYCERYL ETHERS; HUMANS; NEOPLASM INVASIVENESS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0032898722     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199902)178:2<173::AID-JCP6>3.0.CO;2-Q     Document Type: Article

References (47)

1. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. 1989. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57:327-334.
2. Bennett SA, Birnboim HC. 1997. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. Mol Carcinog 20:366-375.
3. Berridge MJ. 1984. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 220:175-178.
4. Bix GJ, Clark GD. 1998. Platelet-activating factor receptor stimulation disrupts neuronal migration in vitro. J Neurosci 18:307-318.
5. Bordier CG, Sellier N, Foucault AP, Le Goffic F. 1996. Purification and characterization of deep sea shark centrophorus squamous liver oil 1-O-alkylglycerol ether lipids. Lipids 31:521-528.
6. Brattain MG, Levine A, Chakrabarty S, Yeoman I, Willson J, Long B. 1984. Heterogeneity of human colon carcinoma. Cancer Metastasis Rev 3:177-191.
7. Breitman T, Selonick S, Collins S. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940.
8. Brohult A. 1960. Alkylglycerols as growth-stimulating substances. Nature 188:591-592.
9. Brohult A, Brohult J, Brohult S, Joelsson I. 1977. Effect of alkoxyglycerols on the frequency of injuries following radiation therapy for carcinoma of the uterine cervix. Acta Obstet Gynecol Scand 56:441-448.
10. Brohult A, Brohult J, Brohult S. 1978. Regression of tumour growth after administration of alkoxyglvcerols. Acta Obstet Gynecol Scand 57:79-83.
11. Brohult A, Brohult J, Brohult S, Joelsson I. 1986. Reduced mortality in cancer patients after administration of alkoxyglycerols. Acta Obstet Gynecol Scand 65:779-785.
12. Chakrabarty S, Jan Y, Brattain MG, Tabon A, Varani J. 1989. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Res 49:2112-2117.
13. Chakrabarty S, Fan D, Varani J. 1990. Regulation of differentiation and cellular proliferation in human colon-carcinoma cells by transforming growth factor β1 and β2. Int J Cancer 46:493-499.
14. Chakrabarty S, Rajagopal S, Huang S. 1995. Expression of antisense epidermal growth factor receptor RNA downmodulated the malignant behavior of human colon cancer cells. Clin Exp Metastasis 13:191-195.
15. Croft SL, Neal RA, Pendergast W, Chan JH. 1987. The activity of alkyl phosphorylcholines and related derivatives against LEISHMANIA DONOVANI. Biochem Pharmacol 36:2633-2636.
16. Daniel LW, Small GW, Schmitt JD. 1988. Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols. Biochem Biophys Res Commun 151:291-297.
17. Denk H, Tappeiner G, Eckerstorfer R, Holzner J. 1972. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor cell differentiation. Int J Cancer 10:262-272.
18. Fatini J, Verrier B, Robert C, Pic P, Pichon J, Mauchamp J, Varvaldi J. 1990. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium. Exp Cell Res 189:109-117.
19. Hallgren B, Larsson S. 1962a. The glycerol ethers in the liver oils of elasmobranch fish. Lipid Res 3:31-38.
20. Hallgren B, Larsson S. 1962b. The glycerol ethers in man and cow. Lipid Res 3:39-43.
21. Hallgren B, Stallberg G, Boeryd B. 1978. Occurrence, synthesis and biological effect of methoxysubstituted ethers. Progress in Chem. of Fats and Other Lipids 16:45.
22. Heby O. 1981. Role of polyamines in the control of cell proliferation and differentiation. Differentiation 19:1-20.
23. Herrmann DBJ, Neumann HA. 1986. Cytotoxic ether phospholipids. J Biol Chem 261:7742-7747.
24. Hong WK, Sporn MB. 1997. Recent advances in chemoprevention of cancer. Science 278:1073-1077.
25. Hoosein N, Brattain D, McKnight M, Childress K, Chakrabarty S, Brattain MG. 1988. Comparison of the antiproliferative effects of transforming growth factor-β, N, N-dimethylformamide and retinoic acid on human colon carcinoma cell lines. Cancer Lett 40:219-232.
26. Huang S, Chakrabarty S. 1994. Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor β. Int J Cancer 57:742-746.
27. Huang S, Trujillo JM, Chakrabarty S. 1992. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor β. Int J Cancer 52:978-986.
28. Huang S, Varani J, Chakrabarty S. 1994. Control of AKR fibroblast phenotype by fibronectin: regulation of cell-surface fibronectin binding receptor by fibronectin. J Cell Physiol 161:470-482.
29. Kitchen E, Rossi AG, Condliffe AM, Haslett C, Chilvers ER. 1996. Demonstration of reversible priming of human neutrophils using platelet-activating factor. Blood 88:4330-4337.
30. Kulikov VI, Muzya GI. 1997. Ether lipids and platelet-activating factor: evolution and cellular function. Biochemistry 62:1103-1108.
31. Langdon S, Hawkes M, Hay F, Lawrie S, Schol D, Hilgers J, Leonard R, Smyth J. 1988. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res 48:6161-6165.
32. Levine AE, Chakrabarty S. 1992. Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N, N-dimethylformamide. Int J Cancer 50:653-658.
33. Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, Modolell M. 1997. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res 57:1320-1328.
34. Mulder K, Brattain MG. 1989. Growth factor expression and response in human colon carcinoma cells. In: Augenlicht LH, editor. Cell and Molecular Biology of Colon Cancer. Boca Raton, FL: CRC Press, p 45-65.
35. Ngwenya BZ, Yamamoto N. 1986. Effects of inflammation products on immune systems: lysophosphatidycholine stimulates macrophages. Cancer Immunol Immunother 21:174-182.
36. Niles R, Wilhelm S, Thomas P, Zamcheck N. 1988. The effects of sodium butyrate and retinoic acid on cell growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation. Cancer Invest 6:39-45.
37. Nishizuka Y. 1984. Turnover of inositol phospholipids and signal transduction. Science 225:1365-1370.
38. Oh S, Jadhav LS. 1994. Effects of dietary alkylglycerols in lactating rats on immune response. Pediatr Res 36:300-305.
39. Orga SS, Weintraub D, Orga PL. 1977. Immunologic aspects of human colostrum and milk. J Immunol 19:245-248.
40. Reynolds S, Rajagopal S, Chakrabarty S. 1998. Differentiation-inducing effect of retinoic acid, difluoromethylornithine, sodium butyrate and sodium suramin in human colon cancer cells. Cancer Letts (in press).
41. Rougier F, Dupuis F, Cornu E, Dulery C, Praloran V, Denizot Y. 1997. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. J Lipid Mediator and Cell Signalling 16:147-153.
42. Schroy P. 1994. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol 161:111-123.
43. Serhan CN, Haggstrom JZ, Leslie CC. 1996. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 10:1147-1158.
44. Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M. 1998. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Am J Physiol 274:C47-C57.
45. Varani J, Chakrabarty S. 1990. Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts. J Cell Physiol 143:445-454.
46. Varani J, Schuger L, Fligiel SEG, Inman DR, Chakrabarty S. 1991. Production of fibronectin by human tumor cells and interation with exogenous fibronectin: comparison of cell lines obtained from colon adenocarcinomas and squamours carcinomas of the upper aerodigestive tract. Int J Cancer 47:421-425.
47. Verdonck LF, van Heugten HG. 1997. Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis. Leuk Res 21: 37-43.